People · Operator
Named in public records as an officer, director or promoter · active 2006–2025 · Other Technology, Biotechnology, Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Axtria, Inc. | — | Other Technology | Series C | $146.2M | $2.4B | 2009 |
| Instylla, Inc. | — | Biotechnology | Series B | $85.5M | $100.3M | 2017 |
| Ocular Therapeutix, Inc | — | Biotechnology | Series B | $81.0M | $1.5B | 2006 |
| Rejoni, Inc. | — | Biotechnology | Series B | $41.0M | $364.1M | 2020 |
| Augmenix Inc | — | Biotechnology | Series A | $40.6M | $216.9M | 2008 |
| Neurolutions Inc | — | Biotechnology | Series B | $26.5M | $144.9M | 2025 |
| Sealonix, Inc. | — | Other | Series B | $19.6M | $160.6M | 2023 |
| StataDx, Inc. | — | Other Health Care | Seed | $4.5M | $9.1M | 2024 |
Amarpreet Sawhney at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Amarpreet Sawhney on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| FARHAD KHOSRAVI | 4 | 14 |
| Tara Butler | 3 | 12 |
| Steven Cagnetta | 3 | 5 |
| Patrick Campbell | 2 | 4 |
| Jaswinder Chadha | 2 | 2 |
| Tasneem Dohadwala | 2 | 2 |
| Richard Lindstrom | 1 | 13 |
| Alan Crane | 1 | 9 |
| Richard L Lindstrom | 1 | 8 |
| Brian Levy | 1 | 8 |
| Henry Chen | 1 | 7 |
| James Garvey | 1 | 6 |
| Kevin Reilly | 1 | 5 |
| Darshana Zaveri | 1 | 5 |
| Charles Warden | 1 | 5 |
| Richard Braddock | 1 | 5 |
| Stavros Vizirgianakis | 1 | 3 |
| Leo Petrossian | 1 | 3 |
| Donald Ingber | 1 | 3 |
| Daniel Myers | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.